Recombinant Human Mesothelin protein (Myc Tag, His Tag)
Species
Human
Purity
>90 %, SDS-PAGE
Tag
Myc Tag, His Tag
Activity
not tested
Cat no : Eg31658
Validation Data Gallery
Product Information
Purity | >90 %, SDS-PAGE |
Endotoxin | <0.1 EU/μg protein, LAL method |
Activity |
Not tested |
Expression | HEK293-derived Human Mesothelin protein Glu296-Ser606 (Accession# Q13421-1) with a Myc tag and a His tag at the C-terminus. |
GeneID | 10232 |
Accession | Q13421-1 |
PredictedSize | 40.1 kDa |
SDS-PAGE | 40-60 kDa, reducing (R) conditions |
Formulation | Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization. |
Reconstitution | Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water. |
Storage Conditions |
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature. |
Background
Mesothelin (MSLN) is a glycosylphosphatidylinositol-linked membrane glycoprotein which is highly expressed in a variety of tumors and is also expressed in mesothelial cells of healthy individuals, but at low levels. Therefore, it can be considered as a promising target protein for tumor-targeted therapy. In the tumor environment, MSLN plays an important role in survival, proliferation, and migration/invasion of cancer cells as well as in drug resistance.
References:
1. Zeng W, et al. (2022) Front Immunol. 13:925217. 2. Schoutrop E, et al. (2021) Cancer Res. 81:3022–35. 3. Weidemann S, et al. (2021) Biomedicines. 9:397. 4. Le K, et al. (2020) Int J Med Sci. 17:422–7. 5. Del Bano J, et al. (2019) Front Immunol.10:1593.